NF-κB to the rescue: RELs, apoptosis and cellular transformation

Trends in Genetics

Volumn 15, Issue 6, 1999, Pages 229-235

  Foo, Shi Yin ^b   Nolan, Garry P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANGIOTENSINOGEN; BETA 2 MICROGLOBULIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GENE PRODUCT; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL;

APOPTOSIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; REGULATOR GENE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; METABOLISM; ONCOGENE;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; MODELS, GENETIC; NF-KAPPA B; ONCOGENES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033141406     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(99)01719-9     Document Type: Review

References (50)

1. 1 Bales, K.R. et al. (1998) The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Brain Res. Mol. Brain Res. 57, 63-72
2. 2 Grilli, M. et al. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274, 1383-1385
3. 3 Ghosh, S. et al. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune response. Annu. Rev. Immunol. 16, 225-260
4. 4 Lin, L. et al. (1998) Cotranslational biogenesis of NF-κB p50 by the 26S proteosome. Cell 92, 819-828
5. 5 Baldwin, A.S. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681
6. 6 May, M.J. and Ghosh, S. (1998) Signal transduction through NF-κB. Immunol. Today 19, 80-88
7. 7 Wulczyn, F.G. et al. (1992) Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of NF-κB. Nature 358, 597-599
8. 8 Franzoso, G. et al. (1992) The candidate proto-oncogene bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359, 339-342
9. 9 Nolan, G.P. et al. (1993) The proto-oncogene bcl-3 encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13, 3557-3566
10. 10 Arenzana-Seisdedos, F. et al. (1995) Inducible nuclear expression of newly synthesized IκB-α negatively regulates DNA-binding and transcriptional activation of NF-κB. Mol. Cell. Biol. 15, 2689-2696
11. 11 Thompson, J. et al. (1995) IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80, 573-582
12. 12 Fracchiolla, N.S. et al. (1993) Structural alterations of the NF-κB transcription factor Lyt-10 in lymphoid malignancies. Oncogene 8, 2839-2845
13. 13 Sovak, M.A. et al. (1997) Aberrant nuclear factor-κB/Rel expression and the pathogensis of breast cancer. J. Clin. Invest. 100, 1952-1960
14. 14 Ciana, P. et al. (1997) Constitutive expression of lymphoma-associated NFKB2/Lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene 14, 1805-1810
15. 15 Grimm, S. et al. (1996) Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134, 13-23
16. 16 Kitajima, I. et al. (1992) Ablation of transplanted HTLV-1 Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258, 1792-1795
17. 17 Beg, A.A. et al. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170
18. 18 Wang, C-Y. et al. (1996) TNF-α and cancer therapy-induced apoptosis:potentiation by inhibition of NF-κB. Science 274, 784-787
19. 19 Liu, Z-G. et al. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576
20. 20 Van Antwerp, D.J. et al. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789
21. 21 Wu, M. et al. (1996) Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16, 5015-5025
22. 22 Wu, M. et al. (1996) Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682-4690
23. 23 Thompson, E.B. (1998) The many roles of c-myc in apoptosis. Annu. Rev. Physiol. 60, 575-560
24. 24 Arsura, M. et al. (1996) TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis in B cells. Immunity 5, 31-40
25. 25 Berberich, I. et al. (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153, 4357-4366
26. 26 Lee, H. et al. (1995) Role of Rel-related factors in control of c-myc gene transcription in receptor-meditaed apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181, 1169-1177
27. 27 Phillips, R.J. and Ghosh, S. (1997) Regulation of IκB-β in WEHI 231 mature B cells. Mol. Cell. Biol. 17, 4390-4396
28. 28 Seitz, C.S. et al. (1998) Alterations in NF-κB function in transgenic epithelial demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. U. S. A. 95, 2307-2312
29. 29 Caamano, J.H. et al. (1996) Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol. Cell. Biol. 16, 1342-1348
30. 30 Ohno, H. et al. (1990) The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991-997
31. 31 Franzoso, G. et al. (1997) Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture and germinal center formation. Immunity 6, 479-490
32. 32 Schwarz, E.M. et al. (1997) Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11, 187-197
33. 33 Kasibhatla, S. et al. (1999) Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor-κB. J. Biol. Chem. 274, 987-992
34. 34 Wu, M.X. et al. (1998) IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281, 998-1001
35. 35 Chu, Z.L. et al. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. U. S. A. 94, 10057-10062
36. 36 Wang, C.Y. et al. (1998) Anti-apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress Caspase 8 activation. Science 281, 1680-1683
37. 37 Herrero, J.A. et al. (1995) LMP-1 activates NF-κB by targeting the inhibitory molecule IκB-α. J. Virol. 69, 2168-2174
38. 38 Sarma, V. et al. (1995) Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270, 12343-12346
39. 39 Wu, H. and Lozano, G. (1994) NF-κB activation of p53. A potential mechanism for suppression of cell growth in response to stress. J. Biol. Chem. 269, 20067-20074
40. 40 Jones, P.L. et al. (1997) Tumor necrosis factor alpha and interleukin-1β regulate the murine manganese superoxide dismutase gene throuh a complex intronic enhancer involving C/EBP-β and NF-κB. Mol. Cell. Biol. 17, 6970-6981
41. 41 Bash, J. et al. (1997) c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell. Biol. 17, 6526-6536
42. 42 Hall, P.A. and Lane, D.P. (1997) Tumor suppressors: a developing role for p53? Curr Biol. 7, R144-R147
43. 43 Shaw, P.H. (1996) The role of p53 in cell cycle regulation. Pathol. Res. Prac. 192, 669-675
44. 44 Hellin, A.C. et al. (1998) Nuclear factor-κB-dependent regulation of p53 expression is induced by daunorubicin genotoxic drug. Oncogene 16, 1187-1195
45. 45 Wadgaonkar, R. et al. (1999) CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J. Biol. Chem. 274, 1879-1882
46. 46 Zhong, H. et al. (1998) Phosphorylation of NF-κB by PKA stimulated transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-671
47. 47 Perkins, N.D. et al. (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527
48. 48 Gerritsen, M.E. et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U. S. A. 94, 2927-2932
49. 49 Neish, A.S. et al. (1998) Factors associated with the mammalian RNA polymerase II holoenzyme complex. Nucleic Acids Res. 26, 847-853
50. 50 Datta, B. et al. (1996) p202, an interferon-inducible modulator of trancription, inhibits transcriptional activation by the p53 tumor suppressor protein and a segment from the p53 protein that binds to p202 overcomes this inhibition. J. Biol. Chem. 271, 27544-27555